Drug toxicity prediction is an important step in ensuring
patient
safety during drug design studies. While traditional preclinical studies
have historically relied on animal models to evaluate toxicity, recent
advances in deep-learning approaches have shown great promise in advancing
drug safety science and reducing animal use in preclinical studies.
However, deep-learning-based approaches also face challenges in handling
large biological data sets, model interpretability, and regulatory
acceptance. In this review, we provide an overview of recent developments
in deep-learning-based approaches for predicting drug toxicity, highlighting
their potential advantages over traditional methods and the need to
address their limitations. Deep-learning models have demonstrated
excellent performance in predicting toxicity outcomes from various
data sources such as chemical structures, genomic data, and high-throughput
screening assays. The potential of deep learning for automated feature
engineering is also discussed. This review emphasizes the need to
address ethical concerns related to the use of deep learning in drug
toxicity studies, including the reduction of animal use and ensuring
regulatory acceptance. Furthermore, emerging applications of deep
learning in drug toxicity prediction, such as predicting drug–drug
interactions and toxicity in rare subpopulations, are highlighted.
The integration of deep-learning-based approaches with traditional
methods is discussed as a way to develop more reliable and efficient
predictive models for drug safety assessment, paving the way for safer
and more effective drug discovery and development. Overall, this review
highlights the critical role of deep learning in predictive toxicology
and drug safety evaluation, emphasizing the need for continued research
and development in this rapidly evolving field. By addressing the
limitations of traditional methods, leveraging the potential of deep
learning for automated feature engineering, and addressing ethical
concerns, deep-learning-based approaches have the potential to revolutionize
drug toxicity prediction and improve patient safety in drug discovery
and development.